Dewhurst Martin William bought TTRX
June 4, 2026 · Form 4 insider transaction
Dewhurst Martin William bought 71,666 shares of Turn Therapeutics Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
71,666
Price
$0.00
Total value
N/A
InsiderDewhurst Martin William
Role—
SecurityStock option (right to buy)
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after71,666
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The option will vest in twelve (12) equal monthly installments, on the last day of each calendar month, commencing on June 30, 2026, subject to the Reporting Person's continued employment and the terms and conditions of the applicable option award and the Issuer's 2025 Omnibus Incentive Plan.